tm
Seeing Is Believing
tm
Seeing Is Believing
CADL is currently covered by 6 analysts with an average price target of $15.38. This is a potential upside of $10.79 (11.85%) from yesterday's end of day stock price of $13.75.
Candel Therapeutics's activity chart (see below) currently has 12 price targets and 22 ratings on display. The stock rating distribution of CADL is 90.91% BUY and 9.09% HOLD.
Analysts average stock forecasts to be materialized ratio is 17.04% with an average time for these price targets to be met of 48.5 days.
Highest price target for CADL is $23, Lowest price target is $7, average price target is $15.38.
Most recent stock forecast was given by ALEC STRANAHAN from BAML on 14-Aug-2026. First documented stock forecast 23-Aug-2021.
Currently out of the existing stock ratings of CADL, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Aug-2026
$12
$-1.13 (-8.61%)
$7
Buy Since 28-Oct-2025
$15
$5.21 (53.22%)
$15
Buy Since 21-Nov-2025
$14
$4.21 (43.00%)
What is CADL (Candel Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CADL (Candel Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CADL (Candel Therapeutics)?
Which analyst is the currently most bullish on CADL (Candel Therapeutics)?
Which analyst is the currently most reserved on CADL (Candel Therapeutics)?
